Maia BiotechnologyMAIA

13F holders, Q3 2024 (September 30)
17holders −4
2new positions
6sold out
$2.83avg. 13F price*

At the end of Q3 2024, 17 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, down 4 from Q2 2024. 2 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($1.6M), Halter Ferguson Financial Inc. ($1.1M) and Geode Capital Management, LLC ($541K).

Company
Maia Biotechnology Inc.
CUSIP
552641102
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 20Q1 2024Q2 2024: 21Q2 2024Q3 2024: 17Q3 2024Q4 2024: 20Q4 2024Q1 2025: 20Q1 2025Q2 2025: 20Q2 2025Q3 2025: 19Q3 2025Q4 2025: 26Q4 2025Q1 2026: 33Q1 2026Q2 2026: 36Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions2$78K
Exits6$213K

All 13F filers, Q2 2024 → Q3 2024: 92,896 shares bought and 414,932 shares sold, net −322,036 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 17 holders

Vanguard Group Inc. 0.00% Add +5.5% 566,374 $1.6M
Halter Ferguson Financial Inc. 0.60% Reduce -47.8% 376,714 $1.1M
Geode Capital Management, LLC 0.00% Add +22.9% 192,563 $541K
BlackRock, Inc. 0.00% — 79,727 $224K
Centric Wealth Management 0.06% Add +0.0% 68,219 $217K
Bridgeway Capital Management, LLC 0.00% No change 45,700 $128K
State Street Corp. 0.00% No change 34,400 $97K
Northern Trust Corp. 0.00% No change 32,071 $90K
Naviter Wealth, LLC 0.01% No change 22,168 $62K
UBS Group AG 0.00% New 16,685 $47K
Wealth Enhancement Advisory Services, LLC 0.00% No change 14,800 $42K
XTX Topco Ltd 0.00% New 10,991 $31K
Morgan Stanley 0.00% No change 5,095 $14K
Tower Research Capital LLC (TRC) 0.00% Reduce -69.1% 1,466 $4K
Bank of America Corp. 0.00% Add +13.9% 156 $438
Sunbelt Securities, Inc. 0.00% No change 100 $281
JPMorgan Chase & Co. 0.00% Add +14.6% 47 $132

"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.